Nerve graft reconstruction of gap defects may result in poor outcomes, particularly with long regeneration distances. Electrical stimulation (ES) of nerves may improve outcomes in such patients. A single session of ES at 20 Hz for 1 hour significantly enhances axon regeneration in animals and human subjects after nerve crush or nerve transection and repair. However, few studies have examined the effect of ES with nerve grafting. Furthermore, it is not known if a second, delayed session of ES has added benefit to an initial session of ES in staged surgical procedures such as cross face nerve grafting for facial reanimation. The objectives of this study were to evaluate if ES enhances axon regeneration through nerve grafts and if there is added benefit of a second, delayed session of ES (serial ES) on axon regeneration as compared to a single session only of ES.
PURPOSE:
Nerve graft reconstruction of gap defects may result in poor outcomes, particularly with long regeneration distances. Electrical stimulation (ES) of nerves may improve outcomes in such patients. A single session of ES at 20 Hz for 1 hour significantly enhances axon regeneration in animals and human subjects after nerve crush or nerve transection and repair. However, few studies have examined the effect of ES with nerve grafting. Furthermore, it is not known if a second, delayed session of ES has added benefit to an initial session of ES in staged surgical procedures such as cross face nerve grafting for facial reanimation. The objectives of this study were to evaluate if ES enhances axon regeneration through nerve grafts and if there is added benefit of a second, delayed session of ES (serial ES) on axon regeneration as compared to a single session only of ES.
METHODS:
Female Sprague Dawley rats were randomized to control (sham ES + sham ES), single ES (ES + sham ES), or serial ES (ES + ES). A 10 mm nerve gap defect in the right common peroneal (CP) nerve was reconstructed with a reversed 20 mm left CP nerve autograft. Bipolar stainless steel electrodes connected to a Grass SD9 stimulator were placed proximal to the autograft for either 1 hour of ES (20 Hz, 0.1 ms pulse duration, 3-5 V) or sham ES (stimulator not turned on) prior to wound closure. After 4 weeks, the right CP nerve autograft was re-exposed and rats received a second 1 hour session of either ES or sham ES of the CP nerve. At 6 weeks after initial surgery, CP neurons that had regenerated axons 5 mm distal to the autograft were retrograde labeled for enumeration and the CP nerve distal to the autograft was harvested for histomorphometry.
RESULTS:
The number of motoneurons (mean ± SD) that regenerated axons through the autograft was significantly higher after single ES (314 ± 70, p<0.01) or serial ES (292 ± 60, p<0.01) as compared to sham ES (182 ± 72). There were significantly more sensory neurons that regenerated their axons after single ES (754 ± 144, p<0.05) or serial ES (769 ± 188, p<0.05) as compared to sham ES (544 ± 165). There was no significant difference in the number of regenerated motor or sensory neurons between rats receiving either single ES or serial ES (p>0.05). There were no significant between group differences for myelinated axon counts on histomorphometry or muscle mass ratios of tibialis anterior or extensor digitorum longus (p>0.05).
CONCLUSION:
A single session of ES enhances axon regeneration following immediate nerve autografting with no added effect of a second, delayed session of ES. These findings support previous studies in animals and humans of the robust effect of a single session of ES in promoting nerve regeneration following injury and repair. ES is a clinically translatable technique that may enhance outcomes following nerve gap reconstructions.
PURPOSE:
Contactin-associated protein-like 4 (Cntnap4) is a member of the neurexin superfamily of transmembrane molecules that have critical functions in neuronal cell communication. For example, global Cntnap4 knockout mice exhibit autism spectrum disorder (ASD)-like behavioral phenotypes. Interestingly, Cntnap4 was recently identified as a specific cell surface receptor of the osteogenic protein, Nell-1, and has a critical role in Nell-1-mediated osteogenesis. By using cranial neural crest cells (CNCCs) specific Cntnap4 knockout mice, this study provides direct evidence that Cntnap4 is a pivotal factor in the development and growth of the craniofacial tissues, thereby introducing a new target for future clinical interventions related to craniofacial anomalies.
METHODS: Cntnap4
flox/flox ; Wnt1-Cre (Cntnap4 Wnt1 KO) mice were generated with specific inactivation of Cntnap4 in Wnt1 expressing CNCCs for comprehensive analysis. Cre negative littermates of the same age and/or gender were used as wild type (WT) control. Mice at neonatal and early postnatal stages were used for this study. Gross examination was performed with particular attention to craniofacial phenotypes. The calvarial vault and base were evaluated using multiple approaches including neonatal skeletal staining, high resolution Micro-CT, histology with cell lineage validation of Cntnap4 inactivation, and immunohistochemistry. Regional calvarial cells from either the frontonasal or parietal bones were used for in vitro osteogenic differentiation experiments.
RESULTS: Forty-seven out of 97 (48%) Cntnap4
Wnt1 KO mice were born alive and matured into adulthood. In comparison to WT controls, neonatal KO revealed severe frontonasal bone defects with mild parietal bone defects in terms of bone density and bone volume at 100% penetrance. The cranial base appeared indistinguishable between KO and WT mice in the bones and synchondroses regardless of being born dead or alive at birth. Among the surviving Cntnap4
Wnt1 KO mice, 32% died of hydrocephalus with premature ossification of the intrasphenoidal synchondrosis and widened frontal, sagittal, and coronal sutures several weeks after birth as revealed by micro-CT and histological analyses. At week 3, both the frontal and parietal bones of KO mice showed a 17% lower bone volume (BV) compared to WT mice. This percentage remained almost the same for the frontal bone at week 7, while a smaller difference (8.5% lower) was observed for the parietal bone in KO mice. Similarly, the bone mineral density (BMD) at week 7 was found to be 7% and 8.8% lower in the frontal and parietal bones of KO mice, respectively. Moreover, the osteogenic capacity of calvarial cells from CNCCs-derived frontonasal bones of KO mice was significantly impaired, which is in agreement with the reduced OCN expression in the tissue sections of KO craniofacial bones.
